Donald William Nicholson
Executive ChairmanDr. Donald William Nicholson, also known as Don, Ph.D., is an Executive Chairman at Disc Medicine, Inc. since April 2019 and serves as its Independent Director since 2019. Dr. Nicholson served as Independent Director of Kymera Therapeutics, Inc. since November 2017 until November 03, 2022. He has been Chairman of the Board at Rezera Inc. He has been Chairman of the Board at Jnana Therapeutics Inc. since February 2019. He serves as an Advisor at Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). since 2017. He served as Independent Director of Generation Bio Co since December 2017 until February 09, 2026. He was Executive Chair of the Board of NodThera since April 2019 until December 2021. He is Executive Chair of the Board of Muna Therapeutics, a biopharmaceutical company, since September 2021. He serves as Director of Matchpoint Therapeutics. Dr. Nicholson served as the Chief Executive Officer at Nimbus Therapeutics, Inc. since August 2014 until October 4, 2018. Dr. Nicholson joined Nimbus from Merck. Dr. Nicholson spent 25 (April 1998 to July 2013) years at Merck & Co., Inc., where he held various strategic, leadership and operational roles in diverse therapeutic areas, including respiratory, inflammation, immunology, bone, endocrine, urology, infectious diseases and neurosciences. He began his career in April 1998 to July 2013 at the Merck-Frosst Centre for Therapeutic Research in Montreal and advanced through various positions of increasing responsibility including Vice President and Site Head of the Merck Neurosciences Research site in San Diego, Calif. He served as Vice President and Worldwide Discovery Head for the Respiratory & Immunology Franchise, in Kenilworth, N.J. He has co-authored more than 150 publications in peer-reviewed scientific and medical journals and is internationally-recognized for his contributions to the field of apoptotic cell death. He is the recipient of multiple academic and professional honors. He served as a Director of at Nimbus Therapeutics, Inc. until October 4, 2018. Dr. Nicholson received his Ph.D. and an Honors Bachelor of Science degree in Biochemistry from the University of Western Ontario and trained as a Medical Research Council Post-Doctoral Fellow at the University of Munich in Germany.
公司職務
- 公司名稱Disc Medicine, Inc.股票代碼IRON職務Executive Chairman共事同僚
- JDJohn D. QuiselCEO, President & Director
- JMJean M. FranchiChief Financial Officer
- JYJonathan YuChief Opearating Officer
- WJWilliam Jacob SavageChief Medical Officer
- BMBrian MacDonaldFounder & Chair of Scientific Advisory Board
- KJKevin J. BittermanIndependent Director
- WRWilliam R. WhiteIndependent Director
